Post stroke spasticity service Use of Botulinum Toxin A (980)
Warning
Spasticity is part of the upper motor neurone syndrome and is common in conditions affecting the brain and spinal cord such as cerebral palsy (CP), acquired brain injury (ABI), stroke (CVA), multiple sclerosis (MS), hereditary spastic paraparesis (HSP) and spinal cord injury (SCI). Botulinum toxin A is a recognised treatment for focal spasticity as well as dystonia. It may be required
to prevent loss of function, secondary complications, help manage pain or before rehabilitation goals can be met.